Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

TherapeuticsMD Free Cash Flow 2012-2024 | TXMD

TherapeuticsMD free cash flow from 2012 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
  
TherapeuticsMD Annual Free Cash Flow
2023 -23.08
2022 9.36
2021 -55.17
2020 -159.68
2019 -168.17
2018 -107.03
2017 -76.22
2016 -69.54
2015 -79.21
2014 -45.55
2013 -20.81
2012 -12.80
2011 -5.00
TherapeuticsMD Quarterly Free Cash Flow
2024-03-31 -0.23
2023-12-31 -23.08
2023-09-30 -18.12
2023-06-30 -12.09
2023-03-31 -8.70
2022-12-31 9.36
2022-09-30 -20.90
2022-06-30 -38.61
2022-03-31 -17.91
2021-12-31 -55.17
2021-09-30 -103.17
2021-06-30 -65.02
2021-03-31 -38.44
2020-12-31 -159.68
2020-09-30 -129.15
2020-06-30 -95.09
2020-03-31 -39.13
2019-12-31 -168.17
2019-09-30 -116.99
2019-06-30 -89.77
2019-03-31 -38.43
2018-12-31 -107.03
2018-09-30 -78.73
2018-06-30 -44.65
2018-03-31 -19.68
2017-12-31 -76.22
2017-09-30 -55.39
2017-06-30 -38.70
2017-03-31 -20.55
2016-12-31 -69.54
2016-09-30 -53.83
2016-06-30 -34.99
2016-03-31 -19.48
2015-12-31 -79.21
2015-09-30 -62.45
2015-06-30 -44.01
2015-03-31 -19.15
2014-12-31 -45.55
2014-09-30 -30.27
2014-06-30 -18.81
2014-03-31 -8.73
2013-12-31 -20.81
2013-09-30 -16.02
2013-06-30 -10.71
2013-03-31 -3.53
2012-12-31 -12.80
2012-09-30 -8.80
2012-06-30 -5.72
2012-03-31 -2.48
2011-12-31 -4.98
2011-09-30 -3.11
2011-06-30 -1.59
2011-03-31 -0.77
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.024B $0.001B
TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.055B 31.33
Chugai Pharmaceutical (CHGCY) Japan $50.402B 22.53
Takeda Pharmaceutical (TAK) Japan $42.567B 8.62
Merck (MKGAF) Germany $22.335B 21.08
Astellas Pharma (ALPMY) Japan $17.626B 27.83
Sandoz Group AG (SDZNY) Switzerland $15.210B 0.00
Neurocrine Biosciences (NBIX) United States $13.936B 38.15
Shionogi (SGIOY) Japan $13.831B 12.02
United Therapeutics (UTHR) United States $11.966B 12.76
Catalent (CTLT) United States $10.048B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.670B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.061B 7.76
Revolution Medicines (RVMD) United States $6.167B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.586B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.496B 0.00
Alpine Immune Sciences (ALPN) United States $4.455B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.894B 0.00
Summit Therapeutics (SMMT) United States $3.289B 0.00
Corcept Therapeutics (CORT) United States $2.880B 26.09
Arrowhead Pharmaceuticals (ARWR) United States $2.845B 0.00
Dyne Therapeutics (DYN) United States $2.461B 0.00
Indivior (INDV) United States $2.417B 11.46
PTC Therapeutics (PTCT) United States $2.391B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.358B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.103B 12.02
Evotec AG (EVO) Germany $1.967B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.948B 18.95
NewAmsterdam Pharma (NAMS) Netherlands $1.830B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.823B 0.00
Ardelyx (ARDX) United States $1.813B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.591B 27.85
Avadel Pharmaceuticals (AVDL) Ireland $1.460B 0.00
Soleno Therapeutics (SLNO) United States $1.453B 0.00
Pacira BioSciences (PCRX) United States $1.435B 13.64
4D Molecular Therapeutics (FDMT) United States $1.331B 0.00
Xencor (XNCR) United States $1.255B 0.00
Enliven Therapeutics (ELVN) United States $1.122B 0.00
Cronos Group (CRON) Canada $1.119B 0.00
Cassava Sciences (SAVA) United States $1.119B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.106B 0.00
Collegium Pharmaceutical (COLL) United States $1.089B 6.51
Ironwood Pharmaceuticals (IRWD) United States $1.038B 16.17
Centessa Pharmaceuticals (CNTA) United Kingdom $1.022B 0.00
ProKidney (PROK) United States $0.945B 0.00
Ocular Therapeutix (OCUL) United States $0.937B 0.00
USANA Health Sciences (USNA) United States $0.906B 14.82
ARS Pharmaceuticals (SPRY) United States $0.870B 0.00
Relay Therapeutics (RLAY) United States $0.844B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.742B 0.00
Sage Therapeutics (SAGE) United States $0.722B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.673B 0.00
Savara (SVRA) United States $0.665B 0.00
Lyell Immunopharma (LYEL) United States $0.648B 0.00
Silence Therapeutics (SLN) United Kingdom $0.633B 0.00
Exscientia (EXAI) United Kingdom $0.603B 0.00
Harrow (HROW) United States $0.575B 0.00
Siga Technologies (SIGA) United States $0.558B 7.14
Altimmune (ALT) United States $0.554B 0.00
OmniAb (OABI) United States $0.527B 0.00
KalVista Pharmaceuticals (KALV) United States $0.527B 0.00
Verve Therapeutics (VERV) United States $0.523B 0.00
Larimar Therapeutics (LRMR) United States $0.503B 0.00
Bioventus (BVS) United States $0.474B 18.15
Lexeo Therapeutics (LXEO) United States $0.460B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.456B 0.00
Heron Therapeutics (HRTX) United States $0.423B 0.00
Esperion Therapeutics (ESPR) United States $0.413B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.403B 0.00
Korro Bio (KRRO) United States $0.402B 0.00
Organogenesis (ORGO) United States $0.377B 71.12
Tourmaline Bio (TRML) United States $0.370B 0.00
Nanobiotix S.A (NBTX) France $0.344B 0.00
Nektar Therapeutics (NKTR) United States $0.325B 0.00
Black Diamond Therapeutics (BDTX) United States $0.323B 0.00
Fractyl Health (GUTS) United States $0.317B 0.00
Nature's Sunshine Products (NATR) United States $0.294B 18.70
Aquestive Therapeutics (AQST) United States $0.291B 0.00
Xeris Biopharma Holdings (XERS) United States $0.282B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.280B 0.00
ESSA Pharma (EPIX) Canada $0.265B 0.00
Akebia Therapeutics (AKBA) United States $0.258B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Pyxis Oncology (PYXS) United States $0.247B 0.00
Metagenomi (MGX) United States $0.245B 0.00
Foghorn Therapeutics (FHTX) United States $0.241B 0.00
Eliem Therapeutics (ELYM) United States $0.227B 0.00
Avita Medical (RCEL) United States $0.225B 0.00
Conduit Pharmaceuticals (CDT) United States $0.210B 0.00
Century Therapeutics (IPSC) United States $0.204B 0.00
Zevra Therapeutics (ZVRA) United States $0.201B 0.00
Profound Medical (PROF) Canada $0.201B 0.00
Adherex Technologies (FENC) United States $0.201B 244.67
Incannex Healthcare (IXHL) Australia $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.189B 0.00
Telomir Pharmaceuticals (TELO) United States $0.187B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Galectin Therapeutics (GALT) United States $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.172B 0.00
MediWound (MDWD) Israel $0.169B 0.00
CytoDyn (CYDY) United States $0.167B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.166B 0.00
Prelude Therapeutics (PRLD) United States $0.162B 0.00
VAXART, INC (VXRT) United States $0.153B 0.00
Elite Pharmaceuticals (ELTP) United States $0.149B 13.95
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.136B 0.00
Karyopharm Therapeutics (KPTI) United States $0.128B 0.00
Context Therapeutics (CNTX) United States $0.128B 0.00
OptiNose (OPTN) United States $0.128B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.127B 8.50
FibroGen (FGEN) United States $0.117B 0.00
PMV Pharmaceuticals (PMVP) United States $0.110B 0.00
Relmada Therapeutics (RLMD) United States $0.110B 0.00
Citius Pharmaceuticals (CTXR) United States $0.109B 0.00
Vivani Medical (VANI) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.096B 4.39
AlloVir (ALVR) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Jaguar Animal Health (JAGX) United States $0.076B 0.00
Tempest Therapeutics (TPST) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.074B 1.05
Marinus Pharmaceuticals (MRNS) United States $0.074B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Protara Therapeutics (TARA) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Carisma Therapeutics (CARM) United States $0.061B 0.00
Inotiv (NOTV) United States $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
BioLineRx (BLRX) Israel $0.052B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.051B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Gain Therapeutics (GANX) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.042B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
Nutriband (NTRB) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.035B 0.00
NRx Pharmaceuticals (NRXP) United States $0.034B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Lipocine (LPCN) United States $0.029B 0.00
DURECT (DRRX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
JanOne (JAN) United States $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.024B 0.00
Lyra Therapeutics (LYRA) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 0.81
PolyPid (PYPD) Israel $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.17